Skip to content
2000
Volume 16, Issue 4
  • ISSN: 2667-3878
  • E-ISSN: 2667-3886

Abstract

Cancer is a worldwide health ailment with no known boundaries in terms of mortality and occurrence rates, thus is one of the biggest threats to humankind. Hence, there is an absolute need to develop novel therapeutics to bridge the infirmities associated with chemotherapy and conventional surgical methodologies, including impairment of normal tissue, compromised drug efficiency and an escalation in side effects. In lieu of this, there has been a surge in curiosity towards the development of injectable hydrogels for cancer therapy because local administration of the active pharmaceutical agent offers encouraging advantages such as providing a higher effective dose at the target site, a prolonged retention time of drug, ease of administration, mitigation of dose in vivo, and improved patient compliance. Furthermore, due to their biocompatible nature, such systems can significantly reduce the side effects that occur on long-term exposure to chemotherapy. The present review details the most recent advancements in the in-situ gel forming polymers (natural and synthetic), polymeric cross-linking methodologies and in-situ gelling mechanisms, focusing on their clinical benefits in cancer therapy.

Loading

Article metrics loading...

/content/journals/raddf/10.2174/2667387816666221005102931
2022-12-01
2025-08-16
Loading full text...

Full text loading...

/content/journals/raddf/10.2174/2667387816666221005102931
Loading

  • Article Type:
    Review Article
Keyword(s): cancer; cross-linking; hydrogels; Injectable; natural polymers; synthetic polymers
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test